Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -3% | 8.2% | 15.1% |
| Success rate | 44% | 68% | 82% |
| Transactions |
12
33% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Independent Director | Lisata Therapeutics Inc | Jan. 22, 2015 - |
| President, Chief Executive Officer and Chief Medical Officer | Galectin Therapeutics Inc | Dec. 14, 2017 - July 6, 2018 |
| President, Chief Executive Officer, Chief Medical Officer, Director | Galectin Therapeutics Inc | March 17, 2011 - Dec. 14, 2017 |
Search